Health Evaluation in African Americans Using RAS Therapy

NCT02471833 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Telmisartan 20mg
DRUG: Telmisartan 40mg
DRUG: Placebo

Sponsor

Emory University

Collaborators

[object Object]